Search

Po-chih Chen

Examiner (ID: 15962, Phone: (571)270-7243 , Office: P/1626 )

Most Active Art Unit
1626
Art Unit(s)
1621, 1626
Total Applications
947
Issued Applications
619
Pending Applications
116
Abandoned Applications
237

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19948337 [patent_doc_number] => 12319684 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-03 [patent_title] => Agonists of the apelin receptor and methods of use thereof [patent_app_type] => utility [patent_app_number] => 17/208919 [patent_app_country] => US [patent_app_date] => 2021-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18784 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208919 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/208919
Agonists of the apelin receptor and methods of use thereof Mar 21, 2021 Issued
Array ( [id] => 18375953 [patent_doc_number] => 20230151034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => PEPTIDOMIMETIC N5-METHYL-N2-(NONANOYL-L-LEUCYL)-L-GLUTAMINATE DERIVATIVES, TRIAZASPIRO[4.14]NONADECANE DERIVATIVES AND SIMILAR COMPOUNDS AS INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION [patent_app_type] => utility [patent_app_number] => 17/911461 [patent_app_country] => US [patent_app_date] => 2021-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68528 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -103 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17911461 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/911461
PEPTIDOMIMETIC N5-METHYL-N2-(NONANOYL-L-LEUCYL)-L-GLUTAMINATE DERIVATIVES, TRIAZASPIRO[4.14]NONADECANE DERIVATIVES AND SIMILAR COMPOUNDS AS INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION Mar 16, 2021 Pending
Array ( [id] => 18995847 [patent_doc_number] => 11912674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-27 [patent_title] => Isoxazole derivatives as nuclear receptor agonists and uses thereof [patent_app_type] => utility [patent_app_number] => 17/191806 [patent_app_country] => US [patent_app_date] => 2021-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36255 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191806 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/191806
Isoxazole derivatives as nuclear receptor agonists and uses thereof Mar 3, 2021 Issued
Array ( [id] => 17096831 [patent_doc_number] => 20210284622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => BIOACTIVE POLYMERS WITH ANTI=FOULING PROPERTIES FOR MEDICAL AND DENTAL USES [patent_app_type] => utility [patent_app_number] => 17/191552 [patent_app_country] => US [patent_app_date] => 2021-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3309 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 444 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191552 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/191552
BIOACTIVE POLYMERS WITH ANTI=FOULING PROPERTIES FOR MEDICAL AND DENTAL USES Mar 2, 2021 Abandoned
Array ( [id] => 17080575 [patent_doc_number] => 20210275581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => Oral Care Composition Containing Cetylpyridinium Tetrachlorozincate [patent_app_type] => utility [patent_app_number] => 17/249489 [patent_app_country] => US [patent_app_date] => 2021-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11201 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17249489 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/249489
Oral Care Composition Containing Cetylpyridinium Tetrachlorozincate Mar 2, 2021 Abandoned
Array ( [id] => 16900676 [patent_doc_number] => 20210179592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => 3-((HETERO-)ARYL)-ALKYL-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/188743 [patent_app_country] => US [patent_app_date] => 2021-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30635 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 1035 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188743 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/188743
3-((HETERO-)ARYL)-ALKYL-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES Feb 28, 2021 Abandoned
Array ( [id] => 16977558 [patent_doc_number] => 20210221795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => AMORPHOUS FORMS OF SELINEXOR AND PROCESS FOR THEIR PREPARATION [patent_app_type] => utility [patent_app_number] => 17/188625 [patent_app_country] => US [patent_app_date] => 2021-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20779 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188625 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/188625
AMORPHOUS FORMS OF SELINEXOR AND PROCESS FOR THEIR PREPARATION Feb 28, 2021 Abandoned
Array ( [id] => 16900679 [patent_doc_number] => 20210179595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => 8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives [patent_app_type] => utility [patent_app_number] => 17/188706 [patent_app_country] => US [patent_app_date] => 2021-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32765 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 1069 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188706 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/188706
8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives Feb 28, 2021 Abandoned
Array ( [id] => 16915768 [patent_doc_number] => 20210188860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives [patent_app_type] => utility [patent_app_number] => 17/188860 [patent_app_country] => US [patent_app_date] => 2021-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46836 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 1065 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188860 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/188860
3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives Feb 28, 2021 Abandoned
Array ( [id] => 16900711 [patent_doc_number] => 20210179627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => 3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives [patent_app_type] => utility [patent_app_number] => 17/188884 [patent_app_country] => US [patent_app_date] => 2021-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32894 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 1295 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188884 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/188884
3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives Feb 28, 2021 Abandoned
Array ( [id] => 16962816 [patent_doc_number] => 20210214315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives [patent_app_type] => utility [patent_app_number] => 17/188802 [patent_app_country] => US [patent_app_date] => 2021-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26459 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 1339 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188802 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/188802
3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives Feb 28, 2021 Abandoned
Array ( [id] => 20663605 [patent_doc_number] => 12605354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-04-21 [patent_title] => Azelaic acid esters in the treatment or prevention of dyslipidemia and associated conditions [patent_app_type] => utility [patent_app_number] => 17/179935 [patent_app_country] => US [patent_app_date] => 2021-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 29 [patent_no_of_words] => 13676 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179935 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/179935
Azelaic acid esters in the treatment or prevention of dyslipidemia and associated conditions Feb 18, 2021 Issued
Array ( [id] => 19638561 [patent_doc_number] => 12169166 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-17 [patent_title] => Fluorogenic cyanine compounds for detecting nucleic acids [patent_app_type] => utility [patent_app_number] => 17/176847 [patent_app_country] => US [patent_app_date] => 2021-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 16056 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176847 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/176847
Fluorogenic cyanine compounds for detecting nucleic acids Feb 15, 2021 Issued
Array ( [id] => 18478262 [patent_doc_number] => 11691992 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-04 [patent_title] => Oxaborole analogs and uses thereof [patent_app_type] => utility [patent_app_number] => 17/173884 [patent_app_country] => US [patent_app_date] => 2021-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 28421 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173884 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/173884
Oxaborole analogs and uses thereof Feb 10, 2021 Issued
Array ( [id] => 18272234 [patent_doc_number] => 20230093476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES AND METHODS OF TREATING REFRACTIVE OCULAR DISORDERS [patent_app_type] => utility [patent_app_number] => 17/759977 [patent_app_country] => US [patent_app_date] => 2021-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19405 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 1409 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759977 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/759977
SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES AND METHODS OF TREATING REFRACTIVE OCULAR DISORDERS Jan 31, 2021 Pending
Array ( [id] => 19519813 [patent_doc_number] => 12121511 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-22 [patent_title] => GLP-1R modulating compounds [patent_app_type] => utility [patent_app_number] => 17/159485 [patent_app_country] => US [patent_app_date] => 2021-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52400 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1365 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17159485 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/159485
GLP-1R modulating compounds Jan 26, 2021 Issued
Array ( [id] => 18666243 [patent_doc_number] => 11773121 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-03 [patent_title] => Antiviral compounds [patent_app_type] => utility [patent_app_number] => 17/157733 [patent_app_country] => US [patent_app_date] => 2021-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8922 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17157733 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/157733
Antiviral compounds Jan 24, 2021 Issued
Array ( [id] => 18285801 [patent_doc_number] => 20230101273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => MESOIONIC INSECTICIDES [patent_app_type] => utility [patent_app_number] => 17/794971 [patent_app_country] => US [patent_app_date] => 2021-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24174 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17794971 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/794971
MESOIONIC INSECTICIDES Jan 22, 2021 Abandoned
Array ( [id] => 20730176 [patent_doc_number] => 12637423 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-05-26 [patent_title] => Aziridinyl functional compound [patent_app_type] => utility [patent_app_number] => 17/792005 [patent_app_country] => US [patent_app_date] => 2021-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11390 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 397 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792005 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/792005
Aziridinyl functional compound Jan 20, 2021 Issued
Array ( [id] => 17141600 [patent_doc_number] => 20210309612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/145453 [patent_app_country] => US [patent_app_date] => 2021-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38065 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 371 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145453 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/145453
Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives Jan 10, 2021 Issued
Menu